Vara nets first CE mark for autonomous AI breast cancer screening tool
Vara has secured a European CE mark for an autonomous, artificial intelligence (AI)-powered breast cancer screening triage tool – marking…
Oncology
-
-
Novocure’s Optune Gio fails to show benefit at earlier stage
Novocure’s stock has dropped more than 15% after its Phase III glioblastoma study of Optune Gio failed to show benefit…
-
Guardant Health acquires MetaSight amid positive 2026 financial outlook
Cancer diagnostics specialist Guardant Health has completed its $149m acquisition of health technology company, MetaSight Diagnostics, as the company gears…
-
Pulse Biosciences and MD Anderson to study nPulse for thyroid cancer
Pulse Biosciences has entered a research partnership with The University of Texas MD Anderson Cancer Center, US, to investigate the…
-
Lunit seeks FDA clearance for breast cancer risk prediction model
Lunit has announced the submission of a 510(k) premarket notification seeking clearance from the US Food and Drug Administration (FDA)…
-
Freenome and Roche partner on cancer screening technology for ex-US markets
Freenome has announced a strategic agreement with Roche aimed at commercialising its cancer screening technology outside the US. Exceeding $200m,…
-
Myriad expands hereditary cancer test to include additional genes
Myriad Genetics has broadened the scope of its MyRisk Hereditary Cancer Test for germline testing, adding genes cited in the…
-
Princess Margaret Cancer Centre and Helix launch genomics study in Canada
Princess Margaret Cancer Centre, part of Canada's University Health Network (UHN), has partnered with genomics company Helix to undertake the…
-
Detect early, save lives: bridging gaps in global breast health
Breast cancer is the most diagnosed cancer in women worldwide. During October, breast cancer awareness month, community outreach should be…
-
Color Health, Google Cloud team up for breast cancer screening access
Color Health, in collaboration with Google Cloud, has unveiled an initiative aimed at increasing the accessibility of breast cancer screening.…
